NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,230,253 | +301.4% | 610,427 | +4165.7% | 0.01% | +400.0% |
| Q1 2022 | $1,054,000 | -95.1% | 14,310 | -90.5% | 0.00% | -95.2% |
| Q4 2021 | $21,536,000 | -64.3% | 150,530 | -48.3% | 0.02% | -67.7% |
| Q3 2021 | $60,359,000 | +223.0% | 291,151 | +230.8% | 0.06% | +225.0% |
| Q2 2021 | $18,687,000 | +236.2% | 88,016 | +187.1% | 0.02% | +185.7% |
| Q1 2021 | $5,559,000 | +38.2% | 30,662 | -15.0% | 0.01% | +40.0% |
| Q4 2020 | $4,021,000 | – | 36,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |